Suppr超能文献

抗凋亡B细胞淋巴瘤2蛋白在内质网-线粒体界面处对钙信号的调节作用

Modulation of Ca Signaling by Anti-apoptotic B-Cell Lymphoma 2 Proteins at the Endoplasmic Reticulum-Mitochondrial Interface.

作者信息

Vervliet Tim, Clerix Eva, Seitaj Bruno, Ivanova Hristina, Monaco Giovanni, Bultynck Geert

机构信息

Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

出版信息

Front Oncol. 2017 May 3;7:75. doi: 10.3389/fonc.2017.00075. eCollection 2017.

Abstract

Mitochondria are important regulators of cell death and cell survival. Mitochondrial Ca levels are critically involved in both of these processes. On the one hand, excessive mitochondrial Ca leads to Ca-induced mitochondrial outer membrane permeabilization and thus apoptosis. On the other hand, mitochondria need Ca in order to efficiently fuel the tricarboxylic acid cycle and maintain adequate mitochondrial bioenergetics. For obtaining this Ca, the mitochondria are largely dependent on close contact sites with the endoplasmic reticulum (ER), the so-called mitochondria-associated ER membranes. There, the inositol 1,4,5-trisphosphate receptors are responsible for the Ca release from the ER. It comes as no surprise that this Ca release from the ER and the subsequent Ca uptake at the mitochondria are finely regulated. Cancer cells often modulate ER-Ca transfer to the mitochondria in order to promote cell survival and to inhibit cell death. Important regulators of these Ca signals and the onset of cancer are the B-cell lymphoma 2 (Bcl-2) family of proteins. An increasing number of reports highlight the ability of these Bcl-2-protein family members to finely regulate Ca transfer from ER to mitochondria both in healthy cells and in cancer. In this review, we focus on recent insights into the dynamic regulation of ER-mitochondrial Ca fluxes by Bcl-2-family members and how this impacts cell survival, cell death and mitochondrial energy production.

摘要

线粒体是细胞死亡和细胞存活的重要调节因子。线粒体钙水平在这两个过程中都起着关键作用。一方面,线粒体钙过量会导致钙诱导的线粒体外膜通透性增加,从而引发细胞凋亡。另一方面,线粒体需要钙来有效地为三羧酸循环提供能量,并维持足够的线粒体生物能量学。为了获取这种钙,线粒体在很大程度上依赖于与内质网(ER)紧密接触的位点,即所谓的线粒体相关内质网膜。在那里,肌醇1,4,5-三磷酸受体负责从内质网释放钙。内质网释放钙以及随后线粒体摄取钙受到精细调节也就不足为奇了。癌细胞常常调节内质网到线粒体的钙转移,以促进细胞存活并抑制细胞死亡。这些钙信号和癌症发生的重要调节因子是B细胞淋巴瘤2(Bcl-2)蛋白家族。越来越多的报告强调了这些Bcl-2蛋白家族成员在健康细胞和癌细胞中精细调节从内质网到线粒体的钙转移的能力。在这篇综述中,我们重点关注Bcl-2家族成员对内质网-线粒体钙通量动态调节的最新见解,以及这如何影响细胞存活、细胞死亡和线粒体能量产生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa42/5413508/6d7d81d6db3a/fonc-07-00075-g001.jpg

相似文献

4
A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
Biochim Biophys Acta. 2014 Oct;1843(10):2240-52. doi: 10.1016/j.bbamcr.2014.04.017. Epub 2014 Apr 21.
5
The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R.
Nat Cell Biol. 2005 Oct;7(10):1021-8. doi: 10.1038/ncb1302. Epub 2005 Sep 18.
6
Endoplasmic Reticulum-Mitochondrial Ca Fluxes Underlying Cancer Cell Survival.
Front Oncol. 2017 May 3;7:70. doi: 10.3389/fonc.2017.00070. eCollection 2017.
8
Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors.
Biochim Biophys Acta. 2013 Apr;1835(2):180-93. doi: 10.1016/j.bbcan.2012.12.001. Epub 2012 Dec 8.
9
IP Receptor Properties and Function at Membrane Contact Sites.
Adv Exp Med Biol. 2017;981:149-178. doi: 10.1007/978-3-319-55858-5_7.
10

引用本文的文献

1
Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function.
Biomedicines. 2025 Jan 17;13(1):223. doi: 10.3390/biomedicines13010223.
2
Apoptotic proteins with non-apoptotic activity: expression and function in cancer.
Apoptosis. 2023 Jun;28(5-6):730-753. doi: 10.1007/s10495-023-01835-3. Epub 2023 Apr 4.
3
Mitochondria-Associated Endoplasmic Reticulum Membranes: Inextricably Linked with Autophagy Process.
Oxid Med Cell Longev. 2022 Aug 23;2022:7086807. doi: 10.1155/2022/7086807. eCollection 2022.
4
Overview of Ca signaling in lung cancer progression and metastatic lung cancer with bone metastasis.
Explor Target Antitumor Ther. 2021;2(3):249-265. doi: 10.37349/etat.2021.00045. Epub 2021 Jun 28.
5
GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients.
Int J Biol Sci. 2022 Apr 11;18(7):2914-2931. doi: 10.7150/ijbs.71571. eCollection 2022.
6
Mitochondria signaling pathways in allergic asthma.
J Investig Med. 2022 Apr;70(4):863-882. doi: 10.1136/jim-2021-002098. Epub 2022 Feb 15.
7
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia.
Nat Cancer. 2021 Nov;2(11):1204-1223. doi: 10.1038/s43018-021-00264-y. Epub 2021 Nov 11.
8
BH3 Mimetics in Hematologic Malignancies.
Int J Mol Sci. 2021 Sep 21;22(18):10157. doi: 10.3390/ijms221810157.
9
The multiple mechanisms of MCL1 in the regulation of cell fate.
Commun Biol. 2021 Sep 2;4(1):1029. doi: 10.1038/s42003-021-02564-6.

本文引用的文献

1
The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca signaling.
Biochim Biophys Acta Mol Cell Res. 2017 Jun;1864(6):968-976. doi: 10.1016/j.bbamcr.2016.11.024. Epub 2016 Nov 30.
2
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
Nature. 2016 Oct 27;538(7626):477-482. doi: 10.1038/nature19830. Epub 2016 Oct 19.
3
ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
Int J Oncol. 2016 Dec;49(6):2507-2519. doi: 10.3892/ijo.2016.3733. Epub 2016 Oct 13.
4
InsP3R, the calcium whisperer: Maintaining mitochondrial function in cancer.
Mol Cell Oncol. 2016 May 11;3(4):e1185563. doi: 10.1080/23723556.2016.1185563. eCollection 2016 Jul.
6
A BH3 Mimetic for Killing Cancer Cells.
Cell. 2016 Jun 16;165(7):1560. doi: 10.1016/j.cell.2016.05.080.
7
The non-apoptotic action of Bcl-xL: regulating Ca(2+) signaling and bioenergetics at the ER-mitochondrion interface.
J Bioenerg Biomembr. 2016 Jun;48(3):211-25. doi: 10.1007/s10863-016-9664-x. Epub 2016 May 7.
8
Onco-IP3Rs Feed Cancerous Cravings for Mitochondrial Ca(2.).
Trends Biochem Sci. 2016 May;41(5):390-393. doi: 10.1016/j.tibs.2016.03.006. Epub 2016 Apr 7.
9
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
Oncotarget. 2016 May 10;7(19):27753-63. doi: 10.18632/oncotarget.8513.
10
Biphasic regulation of InsP3 receptor gating by dual Ca2+ release channel BH3-like domains mediates Bcl-xL control of cell viability.
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1953-62. doi: 10.1073/pnas.1517935113. Epub 2016 Mar 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验